This study is one of the larger disease-related studies concurrently investigating both genotypic/haplotypic variants and serum concentrations in a white population (Supplementary Table 1) and is the first to demonstrate an association between serum MBL concentrations, but not genotype, and recurrence of CDI within 90 days using two distinct cutoff values for MBL deficiency. The gene discussed is MBL2; the disease is hyperinsulinemic hypoglycemia, familial, 4.